• Bristol-Myers wins FDA nod for novel antipsychotic

  • Sep 27 2024
  • Length: 5 mins
  • Podcast

Bristol-Myers wins FDA nod for novel antipsychotic

Listen for free

View show details

  • Summary

  • Bristol-Myers (BMY) wins FDA nod for first-of-its-kind antipsychotic. (00:25) DirecTV, Dish (SATS) close in on merger to form largest US pay-TV service: Bloomberg. (01:11) Major Trump Media (DJT) shareholder dumps nearly entire stake. (02:18)

    Episode transcripts seekingalpha.com/wsb.

    Show links:
    Hurricane Helene misses 'most prolific' Gulf of Mexico oil and gas producing areas
    U.S. and Intel could close $8.5B chip funding by year-end - report
    Intel said to rebuff approach by Arm Holdings for product unit

    Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
    Show more Show less
Show more Show less

What listeners say about Bristol-Myers wins FDA nod for novel antipsychotic

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available